药明生物2025年净利润同比劲增46.3%至49.1亿元,业绩亮眼。其背后是创始人李革、赵宁夫妇二十余年的创业传奇。这对北大留美博士夫妻,怀抱“让天下没有难做的药”的梦想回国,将公司从4人团队发展为行业巨头。已故妻子赵宁罹癌20年仍奋战一线,直至辞世。创业“夫妻档”的传奇故事,是一部温商智慧、科学精神与生命韧性的三重奏。逆势增长:药明生物年赚49.1亿背后的硬实力2026年2月11日,药明生物在...
Source Link药明生物2025年净利润同比劲增46.3%至49.1亿元,业绩亮眼。其背后是创始人李革、赵宁夫妇二十余年的创业传奇。这对北大留美博士夫妻,怀抱“让天下没有难做的药”的梦想回国,将公司从4人团队发展为行业巨头。已故妻子赵宁罹癌20年仍奋战一线,直至辞世。创业“夫妻档”的传奇故事,是一部温商智慧、科学精神与生命韧性的三重奏。逆势增长:药明生物年赚49.1亿背后的硬实力2026年2月11日,药明生物在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.